Produkty 121021-51-0

CAS 121021-51-0 występuje w naszej ofercie pod nazwami: 6β-Hydroxymethylandrosta-1,4-diene-3,17-dione, >95% (HPLC), 6beta-Hydroxymethylandrosta-1,4-diene-3,17-dione. Oferty producentów: TRC, Mikromol. Dostępne opakowania: 100mg, 250mg, 25mg.

6β-Hydroxymethylandrosta-1,4-diene-3,17-dione, >95% (HPLC)
TRC
  • opakowanie: 100mg, 250mg, 25mg
  • Warianty: 3
Zobacz produkt
6beta-Hydroxymethylandrosta-1,4-diene-3,17-dione
Mikromol
  • opakowanie: 25mg
  • Warianty: 1
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(6R,8R,9S,10R,13S,14S)-6-(hydroxymethyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-dione (CAS 121021-51-0) to związek chemiczny o wzorze sumarycznym C20H26O3 i masie molowej 314.4 g/mol. Nazwa systematyczna IUPAC: (6R,8R,9S,10R,13S,14S)-6-(hydroxymethyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-dione. InChIKey: DAXJNUBSBFUTRP-JKNDIDBPSA-N.

Dane identyfikacyjne
Wzór sumarycznyC20H26O3
Masa molowa314.4 g/mol
Nazwa IUPAC(6R,8R,9S,10R,13S,14S)-6-(hydroxymethyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-dione
InChIKeyDAXJNUBSBFUTRP-JKNDIDBPSA-N
SMILESC[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)C[C@H](C4=CC(=O)C=C[C@]34C)CO

Dane obliczone przez PubChem (NCBI)

Synonimy: 6beta-Hydroxymethylandrosta-1,4-diene-3,17-dione, Exemestane Impurity 9, 6?-Hydroxymethylandrosta-1,4-diene-3,17-dione, Exemestane Impurity 24, 6beta-(Hydroxymethyl)androsta-1,4-diene-3,17-dione
Powiązane formy tego związku
(8R,9S,10R,13S,14S)-6-(hydroxymethyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-dione C20H26O3
Izomery (ten sam wzór sumaryczny)
(8S,13S,14S)-13-methylspiro[1,2,4,6,7,8,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,2'-1,3-dioxolane]-17-one C20H26O3
2-tert-butyl-1-[2-(4-methoxyphenoxy)ethoxy]-4-methylbenzene C20H26O3
trans-(2R,3S)-2-ethyl-3-hydroxy-2-[(2E)-2-(6-methoxy-3,4-dihydro-2H-naphthalen-1-ylidene)ethyl]cyclopentan-1-one C20H26O3
(6R,8R,9S,10R,13S,14S,17R)-17-ethynyl-6,17-dihydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one C20H26O3
(2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-3-oxocyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid C20H26O3
(8S,13S,14S,17R)-17-acetyl-17-hydroxy-13-methyl-1,2,4,6,7,8,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one C20H26O3
[(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] acetate C20H26O3
(8S,13S,14S,17S)-17-acetyl-17-hydroxy-13-methyl-1,2,4,6,7,8,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one C20H26O3
(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-3-oxocyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid C20H26O3
(1S,4S,12S,13R,16R,17R)-17-(hydroxymethyl)-12-methyl-8-oxapentacyclo[14.2.1.01,13.04,12.05,9]nonadeca-5(9),6,10-trien-17-ol C20H26O3
(5S,8R,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-2,4,5,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6-dione C20H26O3